Key result
Women with ACHD undergo ~28% fewer Pap tests than the national average alongside reduced mammography.
Why the study?
Do adult women with congenital heart disease have lower cancer screening rates compared to non-ACHD cardiac patients and the general population?
Observational (n=140)
No
Do adult women with congenital heart disease have lower cancer screening rates compared to non-ACHD cardiac patients and the general population?
Absolute Event Rate: 60% vs 83%
p-value: p=<0.001
Adult women with congenital heart disease receive inadequate cancer screening compared to the general population and non-ACHD cardiac patients, indicating a need for improved preventive care collaboration.
Women with congenital heart disease may face screening gaps needing cardiologist attention; leaves open whether interventions close disparities or affect outcomes.
Adults with congenital heart disease (ACHD) face noncardiac healthcare challenges as the population ages. We assessed whether women with ACHD have comparable cancer screening rates to non-ACHD women in a cardiac practice and to the general population. We performed a retrospective review of 175 adult women seen in a cardiac care center in 2009-2011. Data on Pap tests, mammography, and colonoscopies, were collected through electronic medical records and primary care provider records. Adequate documentation was available for 100 individuals with ACHD and 40 comparator cardiac patients. The adequacy of screening was determined using guidelines set forth by the American Cancer Society in 2010. Compared with the national average, ACHD patients had significantly lower rates of Pap tests (60% versus 83%, P < 0.001) and mammography (48% versus 72%, P < 0.001). Compared with non-ACHD women in the same practice, ACHD patients had consistently lower rates of mammography (48% versus 81%, P = 0.02) and colonoscopies (54% versus 82%, P = 0.23). As the population of ACHD individuals ages, attention to cancer screening becomes increasingly important but may be overlooked in this population. Primary care physicians and cardiologists should collaborate to ensure appropriate cancer screening for this growing population.
No takes yet. Share an insight, caveat, or question.
Christman et al. (2013) conducted an observational in Congenital heart disease (n=140). Congenital heart disease vs. Non-ACHD cardiac patients and the national average was evaluated on Pap test screening rate (p=<0.001). Adult women with congenital heart disease had significantly lower rates of Pap tests (60% vs 83%, P<0.001) and mammography (48% vs 72%, P<0.001) compared with the national average.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: